Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
symbol | company | %chng | last | %short | avg$volume | |
---|---|---|---|---|---|---|
PFE | Pfizer Inc. | 0.03% | 36.71 | 0.9% | $1161.89m | |
JNJ | Johnson & Johnson | -0.01% | 160.28 | 0.7% | $1077.05m | |
LLY | Eli Lilly & Co. | 0.01% | 190.79 | 1.1% | $703.48m | |
ABBV | AbbVie, Inc. | -0.03% | 110.49 | 1.9% | $703.16m | |
MRK | Merck & Co., Inc. | 0.00% | 83.38 | 0.7% | $683.91m | |
BMY | Bristol-Myers Squibb Co. | 0.03% | 66.56 | 1.0% | $677.82m | |
AZN | AstraZeneca Plc | 0.00% | 51.34 | 1.2% | $630.16m | |
ARCT | Arcturus Therapeutics Holdings, Inc. | 0.00% | 59.69 | 0.0% | $205.25m | |
VTRS | Viatris, Inc. | 0.00% | 17.05 | 0.0% | $192.05m | |
RPRX | Royalty Pharma Plc | 0.00% | 51.95 | 0.2% | $173.88m | |
NVS | Novartis AG | 0.00% | 95.63 | 0.2% | $170.63m | |
GSK | GlaxoSmithKline Plc | -0.01% | 38.47 | 0.2% | $140.21m | |
SNY | Sanofi | 0.00% | 49.39 | 0.2% | $113.78m | |
RGEN | Repligen Corp. | 0.00% | 215.47 | 6.9% | $75.65m | |
NVO | Novo Nordisk A/S | 0.00% | 72.03 | 0.1% | $70.83m |
Company Profile
Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wenji Bao in 2002 and is headquartered in Boston, MA.